GPT Healthcare [GPTHEALTH] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison
GPT Healthcare
NSE
Loading...
Dr. Agarwal's Eye
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: GPT Healthcare wins in 11 metrics, Dr. Agarwal's Eye wins in 8 metrics, with 0 ties. GPT Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | GPT Healthcare | Dr. Agarwal's Eye | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.09 | 37.83 | GPT Healthcare |
| Price-to-Book Ratio | 5.25 | 9.87 | GPT Healthcare |
| Debt-to-Equity Ratio | 14.24 | 158.94 | GPT Healthcare |
| PEG Ratio | 12.96 | 452.67 | GPT Healthcare |
| EV/EBITDA | 18.98 | 20.08 | GPT Healthcare |
| Profit Margin (TTM) | 12.26% | 13.76% | Dr. Agarwal's Eye |
| Operating Margin (TTM) | 15.60% | 21.43% | Dr. Agarwal's Eye |
| EBITDA Margin (TTM) | 15.60% | 21.43% | Dr. Agarwal's Eye |
| Return on Equity | 21.41% | 29.80% | Dr. Agarwal's Eye |
| Return on Assets (TTM) | 11.02% | 8.91% | GPT Healthcare |
| Free Cash Flow (TTM) | $174.71M | $-83.80M | GPT Healthcare |
| Dividend Yield | 1.57% | 0.11% | GPT Healthcare |
| 1-Year Return | -9.06% | 14.28% | Dr. Agarwal's Eye |
| Price-to-Sales Ratio (TTM) | 3.20 | 5.21 | GPT Healthcare |
| Enterprise Value | $14.63B | $23.79B | Dr. Agarwal's Eye |
| EV/Revenue Ratio | 3.59 | 5.99 | GPT Healthcare |
| Gross Profit Margin (TTM) | 62.52% | 58.37% | GPT Healthcare |
| Revenue per Share (TTM) | $50 | $845 | Dr. Agarwal's Eye |
| Earnings per Share (Diluted) | $6.08 | $116.30 | Dr. Agarwal's Eye |
| Beta (Stock Volatility) | N/A | -0.35 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
GPT Healthcare vs Dr. Agarwal's Eye Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| GPT Healthcare | -1.76% | -9.22% | -4.82% | 5.07% | 9.67% | -10.79% |
| Dr. Agarwal's Eye | -1.47% | 3.27% | 1.73% | 11.57% | 15.69% | -30.24% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| GPT Healthcare | -9.06% | -19.10% | -19.10% | -19.10% | -19.10% | -19.10% |
| Dr. Agarwal's Eye | 14.28% | 471.47% | 1,869.17% | 3,014.69% | 5,475.68% | 10,378.65% |
Performance & Financial Health Analysis: GPT Healthcare vs Dr. Agarwal's Eye
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Market Information | ||
| Market Cap | ₹13.02B | ₹20.68B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 626,491 | 1,388 |
| 90 Day Avg. Volume | 655,872 | 1,413 |
| Last Close | ₹160.54 | ₹4,449.75 |
| 52 Week Range | ₹126.10 - ₹208.45 | ₹3,500.00 - ₹7,300.00 |
| % from 52W High | -22.98% | -39.04% |
| All-Time High | ₹219.90 (Feb 26, 2024) | ₹7,300.00 (Dec 30, 2024) |
| % from All-Time High | -26.99% | -39.04% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.21% |
| Quarterly Earnings Growth | 0.01% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.14% |
| Operating Margin (TTM) | 0.16% | 0.21% |
| Return on Equity (TTM) | 0.21% | 0.30% |
| Debt to Equity (MRQ) | 14.24 | 158.94 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹30.21 | ₹445.96 |
| Cash per Share (MRQ) | ₹4.44 | ₹52.76 |
| Operating Cash Flow (TTM) | ₹673.96M | ₹944.80M |
| Levered Free Cash Flow (TTM) | ₹224.99M | ₹-279,437,504 |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.57% | 0.11% |
| Last 12-Month Dividend | ₹2.50 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: GPT Healthcare vs Dr. Agarwal's Eye
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.09 | 37.83 |
| Forward P/E | 16.68 | 452.67 |
| PEG Ratio | 12.96 | 452.67 |
| Price to Sales (TTM) | 3.20 | 5.21 |
| Price to Book (MRQ) | 5.25 | 9.87 |
| Market Capitalization | ||
| Market Capitalization | ₹13.02B | ₹20.68B |
| Enterprise Value | ₹14.63B | ₹23.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.59 | 5.99 |
| Enterprise to EBITDA | 18.98 | 20.08 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.35 |
| Book Value per Share (MRQ) | ₹30.21 | ₹445.96 |
Financial Statements Comparison: GPT Healthcare vs Dr. Agarwal's Eye
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Revenue/Sales | ₹1.07B | ₹998.30M |
| Cost of Goods Sold | ₹410.93M | ₹415.60M |
| Gross Profit | ₹660.15M | ₹582.70M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹111.83M | ₹213.90M |
| EBITDA | ₹189.28M | ₹316.90M |
| Pre-Tax Income | ₹111.14M | ₹186.00M |
| Income Tax | ₹34.32M | ₹26.10M |
| Net Income (Profit) | ₹76.82M | ₹159.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Cash & Equivalents | ₹16.59M | ₹111.60M |
| Total Current Assets | ₹788.16M | ₹559.40M |
| Total Current Liabilities | ₹742.43M | ₹869.80M |
| Long-Term Debt | ₹227.25M | ₹3.06B |
| Total Shareholders Equity | ₹2.48B | ₹2.10B |
| Retained Earnings | ₹887.46M | N/A |
| Property, Plant & Equipment | ₹2.27B | ₹3.65B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 626,491 | 1,388 |
| Average Daily Volume (90 Day) | 655,872 | 1,413 |
| Shares Outstanding | 82.05M | 4.70M |
| Float Shares | 27.42M | 1.11M |
| % Held by Insiders | 0.68% | 0.78% |
| % Held by Institutions | 0.13% | 0.02% |
Dividend Analysis & Yield Comparison: GPT Healthcare vs Dr. Agarwal's Eye
| Metric | GPTHEALTH | DRAGARWQ |
|---|---|---|
| Last 12-Month Dividend | ₹2.50 | ₹5.00 |
| Last 12-Month Dividend Yield | 1.57% | 0.11% |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹4.50 |
| 3-Year Avg Dividend Yield | 0.73% | 0.12% |
| 3-Year Total Dividends | ₹5.00 | ₹13.50 |
| Ex-Dividend Date | Jul 29, 2025 | Nov 08, 2024 |